Cary Cummings
Internal Medicine · Harrisburg, PANPI 1366407165
Payments from drug & device makers
Across 144 payments — averaging $20.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$500
- AbbVie$399
- Bayer$311
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$221
- Amgen$207
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$195
- plus $1K from 19 others
What the payments were for
- Food & beverage$2,43781%
- Education$56119%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 1 | $500 |
| AbbVie | 25 | $399 |
| Bayer | 15 | $311 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $221 |
| Amgen | 12 | $207 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 11 | $195 |
| Lilly USA, LLC | 11 | $183 |
| GSK | 11 | $160 |
| AstraZeneca(2 entities) | 10 | $157 |
| Novo Nordisk | 7 | $112 |
| Travere Therapeutics, Inc. | 5 | $104 |
| Otsuka America Pharmaceutical, Inc. | 2 | $72 |
| Nestle Healthcare Nutrition Inc. | 4 | $69 |
| Pfizer | 3 | $56 |
| E.r. Squibb & Sons, L.L.C. | 2 | $42 |
| Mallinckrodt Hospital Products Inc. | 1 | $32 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Philips North America LLC | 2 | $29 |
| ANI Pharmaceuticals, Inc. | 1 | $26 |
| Boehringer Ingelheim | 1 | $18 |
| Exact Sciences | 1 | $18 |
| Neurelis, Inc. | 1 | $17 |
| Vifor Pharma, Inc. | 1 | $16 |
| Greenwich Biosciences, Inc. | 1 | $12 |
| Daiichi Sankyo Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BIIM$500
How this compares
$2,998 in reported general payments places this provider in the 85th percentile of 5,705 internal medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 20 | $33,870 |
| XareltoRivaroxaban | 35 | $25,982 |
| Repatha SureclickEvolocumab | 15 | $24,134 |
| FarxigaDapagliflozin Propanediol | 16 | $23,232 |
| JardianceEmpagliflozin | 17 | $21,440 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $20,115 |
| MounjaroTirzepatide | 12 | $14,406 |
| JanuviaSitagliptin Phosphate | 15 | $13,471 |
| Verapamil Er PmVerapamil Hcl | 12 | $5,569 |
| Atorvastatin Calcium | 202 | $4,190 |
| Rosuvastatin Calcium | 66 | $2,354 |
| Amlodipine Besylate | 183 | $1,715 |
| Metoprolol Succinate | 55 | $1,499 |
| Potassium Chloride | 42 | $1,445 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 12 | $1,423 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $56 | $33,87020 claims |
| AstraZenecaFarxiga | $157 | $23,23216 claims |
| Boehringer IngelheimJardiance | $18 | $21,44017 claims |
| GSKTrelegy Ellipta | $160 | $20,11527 claims |
| Lilly USA, LLCMounjaro | $183 | $14,40612 claims |
| ANI Pharmaceuticals, Inc.Valsartan | $26 | $1,25213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 5,705 internal medicine providers in Pennsylvania.
Other internal medicine in Harrisburg
- Jonathan EpsteinPhiladelphia$13.1M
- Siddharth ShethPittsburgh$11M
- Nathan PatelTannersville$9.5M
- Pitamber DevgonPhiladelphia$7.5M
- Christopher StillDanville$7.1M
- Liza VillaruzPittsburgh$6.6M
- Paul HartleyUniontown$4.9M
- Victor KoladeSayre$4.7M
- Michael OliverBeaver$4.7M
- Raman PurighallaPittsburgh$3.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.